and the chances of that happening appear considerably more likely if the deal goes through and Sanofi can exert its marketing muscle and diabetes network in support of the drug. “Given our ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

Sanofi India on Tuesday said it has launched its diabetes drug Soliqua in the country. The company introduced the medication after receiving the marketing authorisation from the Central Drugs ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.

Sanofi meets estimates for fourth-quarter ... insulin makers of charging astronomically high prices for the diabetes drug. Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly ...

The study will compare drug effects on glucose levels, adverse effects ... Additional support in the form of donation of supplies comes from the National Diabetes Education Program, Sanofi-Aventis, ...

Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.